Screener
Arbutus Biopharma Corporation ABUS Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The source filing: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001447028-26-000021
FAQ
- What is Arbutus Biopharma Corporation's net margin?
- Arbutus Biopharma Corporation (ABUS) reported net margin of 84% in Q1 2026.
- How has Arbutus Biopharma Corporation's net margin changed year-over-year?
- Arbutus Biopharma Corporation's net margin increased by 107.0% year-over-year, from -1,195.9% to 84%.
- What is the long-term trend for Arbutus Biopharma Corporation's net margin?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's net margin has grown at a -23.7% compound annual growth rate (CAGR), from -922% to -237.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Arbutus Biopharma Corporation's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude